ImmunONE
Healthcare & Life Sciences
Recent Finacing
Equity
Recent Raise
$0.8M
ImmunONE develops a 3D human lung model that replaces animal testing, allowing companies to assess the safety of new drugs and meet legal requirements.
Focus Areas
3D Human Lung Model
Animal Testing Alternative
Drug Safety Assessment
Biotechnology
Research and Development
Laboratory-grown Tissue
Investors
